Results 1 to 10 of about 82,568 (267)

Hemp Extract (Extractum Cannabis) in the Treatment of Gastrointestinal Distress and Dyspepsia: Historical Insights from Barcelona, Spain

Pharmaceuticals
This study explores the trajectory of interest in and use of Extractum Cannabis (hemp extract, i.e., extract of Cannabis sativa L.) for the symptomatic treatment of minor gastrointestinal distress and dyspepsia in nineteenth- and early twentieth-century ...
Kenzi Riboulet-Zemouli, Josep Allué Creus   +1 more
doaj   +1 more source

Effects and safety of a CBD-rich Cannabis sativa oil in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial – CANOA – cannabis for osteoarthritis

Frontiers in Pharmacology
Osteoarthritis is a common inflammatory and degenerative joint disease characterized by associated chronic pain, often ensuing to diminished quality of life.
Andrés Mojoli, Osvaldo Haider, Yasmin Fakih, Maria Victoria Luz Gonçalves, Bruno Zepeda Rojas, Giovanna Xaia, Emanuelly Krefta, Maíra Assunção Bicca, Thiago Lopes de Mari, Charles Francisco Ferreira, Fernando Cezar-Dos-Santos, Aline Theodoro Toci, Francisney Pinto Nascimento   +12 more
doaj   +1 more source

Harnessing Cannabis sativa as a dual-use platform for biohydrogen production and pharmaceutical synthesis: a hypothesis and theory

Frontiers in Plant Science
Cannabis sativa, long established as a cornerstone of the pharmaceutical and industrial fiber markets, represents a radical and underexplored platform for renewable energy innovation.
Lei P. Wang, Lei P. Wang, Babak Baban, Babak Baban   +3 more
doaj   +1 more source

Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment

Frontiers in Pharmacology
IntroductionCanine osteoarthritis (OA) is a prevalent disease characterized by progressive joint degeneration, pain, and impaired mobility. In older dogs, OA affects approximately 80% of the population.
Neide Maria Griebeler, Ricardo Penayo Cremonese, Yasmin Rafaela Fakih Correa, Priscila Romero Mazzini Pereira, Amanda Furjan Rial, Emanuela Leite, Maria Victoria Luz Gonçalves, Luiz Renato Marques das Almas, Nedice Borges Cardoso, Fernando Cezar-dos-Santos, Aline Theodoro Toci, Andrés Mojoli Le-Quesne, Francisney Pinto Nascimento   +12 more
doaj   +1 more source

Caractéristiques des Canadiens qui utilisent des produits de vapotage en fonction de leur usage du tabac : résultats de l’Enquête sur la santé dans les collectivités canadiennes de 2020

Promotion de la santé et prévention des maladies chroniques au Canada
IntroductionÀ ce jour, la surveillance du vapotage chez les Canadiens (qu’ils utilisent des produits de vapotage contenant de la nicotine ou n’en contenant pas) a largement été analysée en fonction de l’âge et de l’usage du tabac ...
Christine D. Czoli, Camille Guertin, Daniel Dubois, Nancy Farrell, Gabriella Luongo, Gillian Williams, Trevor Mischki   +6 more
doaj   +1 more source

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy

Brain and Behavior
Background A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs) have shown promise as a potential therapy.
Isaac Cowley, Simon Erridge, Arushika Aggarwal, Lilia Evans, Madhur Varadpande, Evonne Clarke, Katy McLachlan, Ross Coomber, Augustin Iqbal, James J Rucker, Mark W Weatherall, Mikael H Sodergren   +11 more
doaj   +1 more source

UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia

Brain and Behavior
Introduction The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for those prescribed cannabis‐based medicinal products (CBMPs) for insomnia.
Kavyesh Vivek, Zekiye Karagozlu, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H Sodergren   +7 more
doaj   +1 more source

Persistent Amotivation After Cannabis-Related Psychosis: Diagnostic Challenges and Clinical Course With Electroconvulsive Therapy: A Case Report. [PDF]

Neuropsychopharmacol Rep
Kitano Y, Takada R, Ikehara M, Yamanaka K, Sunami Y, Okada T.   +5 more
europepmc   +1 more source

UK Medical Cannabis Registry: A Two-Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia. [PDF]

Neuropsychopharmacol Rep
Koye A, Erridge S, Clarke E, McLachlan K, Coomber R, Rucker JJ, Weatherall MW, Sodergren MH.   +7 more
europepmc   +1 more source

Risk factors for adolescent cannabis use following partial cannabis legalization in Germany: a cross-sectional study in secondary schools. [PDF]

Subst Abuse Treat Prev Policy
Trümpelmann M, Lüthgen M, Burgard A, Axt P, Faesser HA, Jagomast T, Weckmann M, Drömann D, Brinkmann F, Penner L, Franzen KF.   +10 more
europepmc   +1 more source